HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Osteogenesis imperfecta type III with intracranial hemorrhage and brachydactyly associated with mutations in exon 49 of COL1A2.

Abstract
Osteogenesis imperfecta (OI) is a heritable bone disorder characterized by fractures with minimal trauma. Intracranial hemorrhage has been reported in a small number of OI patients. Here we describe three patients, a boy (aged 15 years) and two girls (aged 17 and 7 years) with OI type III who suffered intracranial hemorrhage and in addition had brachydactyly and nail hypoplasia. In all of these patients, OI was caused by glycine mutations affecting exon 49 of the COL1A2 gene, which codes for the most carboxy-terminal part of the triple-helical domain of the collagen type I alpha 2 chain. These observations suggest that mutations in this region of the collagen type I alpha 2 chain carry a high risk of abnormal limb development and intracranial bleeding.
AuthorsEissa Faqeih, Peter Roughley, Francis H Glorieux, Frank Rauch
JournalAmerican journal of medical genetics. Part A (Am J Med Genet A) Vol. 149A Issue 3 Pg. 461-5 (Mar 2009) ISSN: 1552-4833 [Electronic] United States
PMID19208385 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Copyright2009 Wiley-Liss, Inc.
Chemical References
  • Collagen Type I
  • Glycine
Topics
  • Adolescent
  • Amino Acid Sequence
  • Child
  • Cohort Studies
  • Collagen Type I (chemistry, genetics)
  • DNA Mutational Analysis
  • Exons (genetics)
  • Female
  • Glycine (genetics)
  • Humans
  • Intracranial Hemorrhages (diagnostic imaging, genetics)
  • Limb Deformities, Congenital (diagnostic imaging, genetics)
  • Male
  • Molecular Sequence Data
  • Mutation
  • Osteogenesis Imperfecta (classification, genetics, pathology)
  • Protein Structure, Tertiary
  • Radiography
  • Ultrasonography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: